Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marisa A. Navo
Observed names:
M. A. Navo,
Marisa Navo
Institution:
Mayo Clinic
Observed institutions:
Mayo Clinic,
The University of Texas MD Anderson Cancer Center,
University of Houston
OpenAlex ID:
A5014292439
An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies
2004
·
Marisa A. Navo
, Julie Phan
, et al.
·
Journal of Clinical Oncology
·
209
Dosing chemotherapy in obese patients: Actual versus assigned body surface area (BSA)
2008
·
Rodney J. Hunter
, Marisa A. Navo
, et al.
·
Cancer Treatment Reviews
·
107
Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients
2006
·
Marisa Navo
, Anuradha Kunthur
, et al.
·
Gynecologic Oncology
·
103
In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines
2007
·
Marisa A. Navo
, Judith A. Smith
, et al.
·
Cancer Chemotherapy and Pharmacology
·
35
Update on the Prevention and Treatment of Ovarian Cancer
2003
·
Marisa Navo
, Judith A. Smith
·
Journal of Pharmacy Practice
·
1
Phase II trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma (LGESS)
2007
·
T. W. Burke
, M. A. Navo
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
6
Citation count:
455
H-index:
4
I10-index:
4
Year
Topic
Type